HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Research analysts at Northland Capmk lifted their Q4 2025 earnings estimates for shares of HIVE Blockchain Technologies in a research note issued to investors on Monday, June 9th. Northland Capmk analyst M. Grondahl now expects that the company will post earnings per share of ($0.08) for the quarter, up from their prior forecast of ($0.09). Northland Capmk also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.08) EPS, Q2 2026 earnings at ($0.03) EPS and FY2026 earnings at $0.00 EPS.
Separately, Rosenblatt Securities raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday, March 7th. Five equities research analysts have rated the stock with a strong buy rating, According to data from MarketBeat, the stock has an average rating of “Strong Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- How to Find Undervalued Stocks
- 3 Tech Focused ETFs to Watch as the Market Nears All-Time Highs
- Most active stocks: Dollar volume vs share volume
- Will Warner Bros. Discovery’s Split Produce Double the Upside?
- Expert Stock Trading Psychology Tips
- Is a Summer Slowdown Ahead for Microsoft Stock?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
